ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for smarter Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.
Artelo Biosciences Inc

Artelo Biosciences Inc (ARTL)

1.25
0.1101
(9.66%)
At close: November 05 4:00PM
1.25
0.00
( 0.00% )
After Hours: 5:43PM

Real-time discussions and trading ideas: Trade with confidence with our powerful platform.

Key stats and details

Current Price
1.25
Bid
1.23
Ask
1.30
Volume
80,061
1.15 Day's Range 1.28
1.00 52 Week Range 1.75
Market Cap
Previous Close
1.1399
Open
1.21
Last Trade
12
@
1.19
Last Trade Time
16:58:44
Financial Volume
$ 96,861
VWAP
1.2098
Average Volume (3m)
9,051
Shares Outstanding
3,227,700
Dividend Yield
-
PE Ratio
-0.43
Earnings Per Share (EPS)
-2.88
Revenue
-
Net Profit
-9.29M

About Artelo Biosciences Inc

Artelo Biosciences Inc is a United States based development-stage biopharmaceutical company. It is focused on discovering, licensing, developing and commercializing treatments that control the endocannabinoid system. The company seeks to pursue technologies and programs that offer proprietary approa... Artelo Biosciences Inc is a United States based development-stage biopharmaceutical company. It is focused on discovering, licensing, developing and commercializing treatments that control the endocannabinoid system. The company seeks to pursue technologies and programs that offer proprietary approaches to cannabinoid-based therapies, including those derived from the cannabis plant and synthetic cannabinoids, as well as new chemical entities and compounds that promote the effectiveness of the endocannabinoid system. The firm's flagship program is designed to be a patent-protected cannabinoid drug combination treatment for a rare and orphan disease. Show more

Sector
Pharmaceutical Preparations
Industry
Pharmaceutical Preparations
Headquarters
Fernley, Nevada, USA
Founded
-
Artelo Biosciences Inc is listed in the Pharmaceutical Preparations sector of the NASDAQ with ticker ARTL. The last closing price for Artelo Biosciences was $1.14. Over the last year, Artelo Biosciences shares have traded in a share price range of $ 1.00 to $ 1.75.

Artelo Biosciences currently has 3,227,700 shares outstanding. The market capitalization of Artelo Biosciences is $3.68 million. Artelo Biosciences has a price to earnings ratio (PE ratio) of -0.43.

ARTL Latest News

Artelo Biosciences Announces Acceptance of ART26.12 into the National Institutes of Health’s β€œPreclinical Screening Platform for Pain” Program

SOLANA BEACH, Calif., Nov. 05, 2024 (GLOBE NEWSWIRE) -- Artelo Biosciences, Inc. (Nasdaq: ARTL), a clinical-stage pharmaceutical company focused on modulating lipid-signaling pathways to develop...

Artelo Biosciences CEO to Participate in Fireside Chat at the Maxim Group Virtual Healthcare Summit on October 16th

SOLANA BEACH, Calif., Oct. 09, 2024 (GLOBE NEWSWIRE) -- Artelo Biosciences, Inc. (Nasdaq: ARTL), a clinical-stage pharmaceutical company focused on modulating lipid-signaling pathways to develop...

Artelo Biosciences to Present at the H.C. Wainwright 26th Annual Global Investment Conference

SOLANA BEACH, Calif., Sept. 04, 2024 (GLOBE NEWSWIRE) -- Artelo Biosciences, Inc. (Nasdaq: ARTL), a clinical-stage pharmaceutical company focused on modulating lipid-signaling pathways to...

Artelo Biosciences Reports Second Quarter 2024 Financial Results and Provides Business Update

SOLANA BEACH, Calif., Aug. 13, 2024 (GLOBE NEWSWIRE) -- Artelo Biosciences, Inc. (Nasdaq: ARTL), a clinical-stage pharmaceutical company focused on modulating lipid-signaling pathways to develop...

Artelo Biosciences Receives FDA Clearance of its IND Application for ART26.12, a Selective Fatty Acid Binding Protein 5 Inhibitor

ART26.12 seeks to address a critical need in painful neuropathies, including chemotherapy-induced peripheral neuropathy for which there is no FDA-approved treatment Phase 1 trial results expected...

Artelo Biosciences Presents Comparative Data from Key Preclinical Studies on ART12.11 at the 34th Annual International Cannabinoid Research Society Symposium

SOLANA BEACH, Calif., July 03, 2024 (GLOBE NEWSWIRE) -- Artelo Biosciences, Inc.Β (Nasdaq:Β ARTL), a clinical-stage pharmaceutical company focused on modulating lipid-signaling pathways to develop...

Artelo Biosciences Announces Data Supporting Broad Potential Utility of its FABP Inhibitor Platform

Inhibition of FABP5 Demonstrates Activity in Cancer, Psoriasis, and Anxiety Disorders Results from Several Research Studies Presented at the Annual ICRS Symposium SOLANA BEACH, Calif., July 02...

Artelo Biosciences Presents Preclinical Data on ART26.12 in Breast Cancer-Induced Bone Pain at the 34th Annual International Cannabinoid Research Society Symposium

SOLANA BEACH, Calif., July 01, 2024 (GLOBE NEWSWIRE) -- Artelo Biosciences, Inc.Β (Nasdaq:Β ARTL), a clinical-stage pharmaceutical company focused on modulating lipid-signaling pathways to develop...

Artelo Biosciences Presents Important New Data on ART26.12 at the 57th Annual Scientific Meeting of the British Pain Society

SOLANA BEACH, Calif., June 04, 2024 (GLOBE NEWSWIRE) -- Artelo Biosciences, Inc.Β (Nasdaq:Β ARTL), a clinical-stage pharmaceutical company focused on modulating lipid-signaling pathways to develop...

Artelo Biosciences Presents Highly Encouraging Data Towards Developing a Solid Dosage Form of ART12.11 at CT-CANN24

SOLANA BEACH, Calif., May 29, 2024 (GLOBE NEWSWIRE) -- Artelo Biosciences, Inc.Β (Nasdaq:Β ARTL), a clinical-stage pharmaceutical company focused on modulating lipid-signaling pathways to develop...

PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
10.18.695652173911.151.251.1101041.1553217CS
40.1210.61946902651.131.29991.07135601.2127833CS
12-0.0101-0.8015236885961.26011.34190511.20721199CS
26-0.1-7.407407407411.351.581460381.32324482CS
52-0.1-7.407407407411.351.751312611.35072018CS
1560.1715.74074074071.087.20.25993654481.14975294CS
260-1.05-45.6521739132.37.20.259912323991.40792262CS

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
ARBBARB IOT Group Ltd
$ 1.3402
(137.41%)
11.34M
QLYSQualys Inc
$ 152.49
(18.92%)
114.51k
TMCITreace Medical Concepts Inc
$ 6.55
(13.72%)
53.09k
PRQRProQR Therapeutics NV
$ 4.0455
(13.00%)
260
MRCYMercury Systems Inc
$ 37.9999
(11.14%)
16.04k
SMCXDefiance Daily Target 2X Long SMCI ETF
$ 1.6297
(-32.10%)
4.05M
EXASEXACT Sciences Corporation
$ 50.04
(-30.02%)
1.64M
AVNWAviat Networks Inc
$ 17.00
(-18.78%)
24.93k
SMCISuper Micro Computer Inc
$ 23.02
(-16.90%)
20.97M
AEHLAntelope Enterprise Holdings Ltd
$ 0.275
(-14.01%)
4.09M
SMCISuper Micro Computer Inc
$ 23.02
(-16.90%)
20.97M
ARBBARB IOT Group Ltd
$ 1.3402
(137.41%)
11.34M
ELABElevai Labs Inc
$ 0.0221
(3.27%)
9.18M
DJTTrump Media and Technology Group Corporation
$ 34.6116
(1.98%)
6.36M
LILMLilium NV
$ 0.0532
(2.31%)
5.54M

ARTL Discussion

View Posts
Monksdream Monksdream 4 months ago
ARTL
πŸ‘οΈ0
glenn1919 glenn1919 4 months ago
artl.........................................https://stockcharts.com/h-sc/ui?s=ARTL&p=W&b=5&g=0&id=p86431144783
πŸ‘οΈ0
Monksdream Monksdream 4 months ago
ARTL under $2
πŸ‘οΈ0
Monksdream Monksdream 8 months ago
ARTL under $2
πŸ‘οΈ0
Monksdream Monksdream 8 months ago
ARTL under $2
πŸ‘οΈ0
Monksdream Monksdream 1 year ago
ARTL under $2
πŸ‘οΈ0
heyitsmeagain heyitsmeagain 2 years ago
Added
πŸ‘οΈ0
heyitsmeagain heyitsmeagain 2 years ago
I’m back ! I’m in pamp
πŸ‘οΈ0
heyitsmeagain heyitsmeagain 2 years ago
Grabbed 7000 more
πŸ‘οΈ0
tw0122 tw0122 2 years ago
Already traded entire float one time let’s do this about 4 more times…
πŸ‘οΈ0
tw0122 tw0122 2 years ago
Now only 2 million float can squeeze to $10 easily. Just a little patience
πŸ‘οΈ0
pistolpete pistolpete 2 years ago
Let’s go $ARTL!!
πŸ‘οΈ0
heyitsmeagain heyitsmeagain 2 years ago
We gonna go artelo $ARTL
πŸ‘οΈ0
heyitsmeagain heyitsmeagain 2 years ago
Got 6000 shares ready to sell at 20
πŸ‘οΈ0
heyitsmeagain heyitsmeagain 2 years ago
Booyaaaaakashaaaa
πŸ‘οΈ0
Arcglass Arcglass 2 years ago
surprised nobody's here yet.
πŸ‘οΈ0
Awl416 Awl416 3 years ago
News
πŸ‘οΈ0
Jake L Jake L 3 years ago
ARTL - Friday Rundown, Monday Expectations

πŸ‘οΈ0
Jake L Jake L 3 years ago
ARTL - Thursday Rundown, Friday Expectations

πŸ‘οΈ0
Jake L Jake L 3 years ago
ARTL - Update

πŸ‘οΈ0
Jake L Jake L 3 years ago
ARTL - Wednesday Rundown, Thursday Expectations

πŸ‘οΈ0
KLee KLee 3 years ago
Sorry guys, wrong board. Blah!
πŸ‘οΈ0
KLee KLee 3 years ago
I have been scooping up so many shares as we dipped under a penny. But that little voice keeps telling me when we blast past our highest I’m going to wish I had scooped more at these levels, trying NOT to be greedy, but damn!!

#CBDD
πŸ‘οΈ0
Jake L Jake L 3 years ago
ARTL - Earnings Insight/Outlook

πŸ‘οΈ0
BUFCARP BUFCARP 3 years ago
More like four wainwright will move this .. look for news coming shortly!
πŸ‘οΈ0
shimanoman shimanoman 3 years ago
.70’s here we come .
πŸ‘οΈ0
Jake L Jake L 3 years ago
ARTL - Friday Rundown, Monday Expectations

πŸ‘οΈ0
BUFCARP BUFCARP 3 years ago
Probably fake shares like most of the market
πŸ‘οΈ0
BONGO68 BONGO68 3 years ago
https://www.chartmill.com/stock/analyzer/stock/ARTL
πŸ‘οΈ0
masterofdisaster masterofdisaster 3 years ago
940,000 short exempts today
πŸ‘οΈ0
masterofdisaster masterofdisaster 3 years ago
Looks like Fintel found shares
πŸ‘οΈ0
masterofdisaster masterofdisaster 3 years ago
Last chance for cheapies
πŸ‘οΈ0
Arcglass Arcglass 3 years ago
Here it comes
πŸ‘οΈ0
Jess070283 Jess070283 3 years ago
Loading up here.$$$$
πŸ‘οΈ0
Arcglass Arcglass 3 years ago
OS Has flipped almost 3 times.
πŸ‘οΈ0
masterofdisaster masterofdisaster 3 years ago
I know but Fintel showing zero shares available. Short exempts will need to be covered
πŸ‘οΈ0
BUFCARP BUFCARP 3 years ago
It’s getting to that point .. short interest is low though
πŸ‘οΈ0
Arcglass Arcglass 3 years ago
$2.00 Target?
πŸ‘οΈ0
make it happen make it happen 3 years ago
Is delinquent for not meeting NASDAQ listing requirements
πŸ‘οΈ0
masterofdisaster masterofdisaster 3 years ago
ARTL MAY SQUEEZE!
πŸ‘οΈ0
masterofdisaster masterofdisaster 3 years ago
Eating up those short shares.....yum....I am ready for the ride to $5
πŸ‘οΈ0
masterofdisaster masterofdisaster 3 years ago
ARTL nice premarket volume
πŸ‘οΈ0
doebop doebop 3 years ago
$$$ nice movement from the <$1 pullback
πŸ‘οΈ0
masterofdisaster masterofdisaster 3 years ago
Easy plays for easy money.....lol
πŸ‘οΈ0
Jake L Jake L 3 years ago
ARTL - Today

πŸ‘οΈ0
Amrsto1000 Amrsto1000 3 years ago
Just came aboard with 25,000.
πŸ‘οΈ0
BUFCARP BUFCARP 3 years ago
After that buy rating by wainwright
πŸ‘οΈ0
make it happen make it happen 3 years ago
It is delinquent.
πŸ‘οΈ0
TIZZUNI TIZZUNI 3 years ago
The stock is alive and running this morning!
πŸ‘οΈ0
jeremyblack jeremyblack 4 years ago
Address: Does anyone know where their office is? I went by recently to thank company for good year and they are no longer there despite posting it on all their filings*.

*their last 8k noted 889 but that does not exist.

thank you.
πŸ‘οΈ0

Your Recent History

Delayed Upgrade Clock